Cochrane COVID-19 Studienregister
Studienbericht
NCT05043350Erstmals veröffentlicht: 2021 Sept 14Letzte Aktualisierung: 2021 Sept 14

Potential Therapeutic Outcome of Combined Antihistaminics Therapy in COVID 19 Patients

  1. Studientyp
  2. Interventional
  1. Studienziel
  2. Treatment and Management
  1. Studiendesign
  2. Parallel/Crossover
  1. Interventionszuordnung
  2. Randomised
Referenzdatensätze

Combined Antihistaminics Therapy in COVID 19 Patients

Ain Shams University
Erstmals veröffentlicht (first received 2021 September 14)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT05043350)
Eintrag in Studienregister
Keine Ergebnisse
The use of antihistaminic medications could result in a significant immune modulation which may help in the treatment of cytokine storm of COVID-19.Thus, the aim of this study is to evaluate efficacy and safety of famotidine and loratadine combination in covid 19 treatment protocol